.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
Deloitte
McKesson
Harvard Business School
Cipla
Queensland Health
Baxter
Accenture
Fish and Richardson
Merck

Generated: February 18, 2018

DrugPatentWatch Database Preview

Patents Expiring in April 2024

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
The Medicines CoIONSYSfentanyl hydrochlorideSYSTEM;IONTOPHORESIS, TRANSDERMAL021338-001May 22, 2006RXYesYes➤ Try a Free Trial➤ Try a Free TrialY
Emd SeronoGONAL-F RFF REDI-JECTfollitropin alfa/betaINJECTABLE;SUBCUTANEOUS021684-001May 25, 2004RXYesYes➤ Try a Free Trial➤ Try a Free TrialY
Emd SeronoGONAL-F RFF REDI-JECTfollitropin alfa/betaINJECTABLE;SUBCUTANEOUS021684-003May 25, 2004RXYesYes➤ Try a Free Trial➤ Try a Free TrialY
Emd SeronoGONAL-F RFF REDI-JECTfollitropin alfa/betaINJECTABLE;SUBCUTANEOUS021684-002May 25, 2004RXYesYes➤ Try a Free Trial➤ Try a Free TrialY
Indivior IncSUBOXONEbuprenorphine hydrochloride; naloxone hydrochlorideFILM;BUCCAL, SUBLINGUAL022410-001Aug 30, 2010RXYesNo➤ Try a Free Trial➤ Try a Free TrialYTREATMENT OF OPIOID DEPENDENCE/SUBLINGUAL OR BUCCAL APPLICATION
Merck Sharp DohmeISENTRESS HDraltegravir potassiumTABLET;ORAL022145-002May 26, 2017RXYesNo➤ Try a Free Trial➤ Try a Free TrialY
Merck Sharp DohmeISENTRESSraltegravir potassiumTABLET;ORAL022145-001Oct 12, 2007RXYesYes➤ Try a Free Trial➤ Try a Free TrialY
Merck Sharp DohmeDUTREBISlamivudine; raltegravir potassiumTABLET;ORAL206510-001Feb 6, 2015DISCNNoNo➤ Try a Free Trial➤ Try a Free TrialY
Merck Sharp DohmeISENTRESSraltegravir potassiumTABLET, CHEWABLE;ORAL203045-002Dec 21, 2011RXYesYes➤ Try a Free Trial➤ Try a Free TrialY
Merck Sharp DohmeISENTRESSraltegravir potassiumPOWDER;ORAL205786-001Dec 20, 2013RXYesYes➤ Try a Free Trial➤ Try a Free TrialY
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
US Army
QuintilesIMS
Julphar
Cerilliant
McKesson
Express Scripts
Deloitte
Colorcon
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot